BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Patent-protected Technology Platform Genvec Pages on BioPortfolio:

BioPortfolio - GenVec
GenVec - Entry on Bioportfolio's Biocorporate Database. ... gene-based therapeutic product candidates use a common patent-protected technology platform
to ...
http://www.bioportfolio.com/biocorporate/534-GenVec.html...

BioPortfolio - Solvo Biotechnology
SOLVO's unique technology platform is built on our core capabilities: ... SOLVO Biotechnology owns a substantial patent portfolio relating to drug targets and
... Our Calcein Assay is protected by US (US5.872.014, US6,277655, ... Cancer
Gene Therapy: GenVec, Inc., Department of Research publishes research in cancer
...
http://www.bioportfolio.com/biocorporate/9649-Solvo+Biotechn...

Results from other life science and pharmaceutical sites:

Beyond Patents and Royalties: Perception and Reality of Doing ...
From new or invigorated activities in technical assistance to technology ..... Patent protection is sought in major non-US markets for discoveries made in NIH
... The platform was further used to develop additional conjugated vaccines such
... As the collaboration progressed, the relationship between GenVec and the ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27...

Information on the Company
vector platform. Protein production. PER.C6 technology can be used as a production ..... Our policy is to actively seek patent protection ... (3)
Technology patent filings primarily relate to cell-based production technology,
adenoviral ..... GenVec and Merck & Co., which may pose a threat to ...
http://www.crucell.com/annual_report_2008/downloads/Crucell_...

Coronary artery angioplasty - BioSpace offers Pharmaceutical ...
... Longer Term Coronary Health Benefits Of The m.doc(TM) Technology Platform And ... Enrollment Has Begun For SpideRX(TM) Embolic Protection Device In Second
Phase ... GenVec Inc. (GNVC) Launches Phase IIB Trial In Patients With Severe
.... European Patent Office Maintains Validity Of Angiotech Pharmaceuticals's
...
http://www.biospace.com/news_by_disease_results.aspx?TheRxId...

Report of the Management Board
protection against the influenza virus, suggesting ... European patents owned or controlled by GenVec, ... patent. These developments further paved the way ...
C6 technology platform together with our partner DSM. Biologics. ...
http://www.crucell.com/annual_report_2008/downloads/Crucell_...

BioSpace offers Pharmaceutical, Biotechnology and Healthcare ...
RxBio, Inc. Release: Novel Compound Affords Protection Against Lethal, .... GenVec Inc. Receives NIAID Biodefense Program Grant For Development Of Broadly
... New Study Confirms Skinvisible, Inc.'s Patent-Pending Chlorhexidine Hand
.... Expand Chimigen"TM" Platform Technology For Use In Biodefense 3/31/2006
More. ...
http://www.biospace.com/news_subject_all_results.aspx?Catago...

Crucell 2008 Combating Infectious Diseases
C6 technology platform together with our partner DSM. Biologics. By employing the PER.C6 human ...... GenVec and Merck & Co., which may pose a threat to .....
product liability litigation, loss of patent protection, ...
http://www.crucell.com/annual_report_2008/downloads/Crucell_...

Malaria - BioSpace offers Pharmaceutical, Biotechnology and ...
Promising Early Data from Phase I/II Clinical Trial Using GenVec Inc. (GNVC) ... Massachusetts Institute of Technology (MIT)-Led Team ID's Cell Mechanics of ...
To Use Its AIPwLV(TM) Platform For Product Development 12/20/2006 More. .... Two
Genetic Traits Giving Africans Malaria Protection Lose Effectiveness When ...
http://www.biospace.com/news_by_disease_results.aspx?TheRxId...

Phase Type - National Institutes of Health (NIH) - Home Page
COM","GENVEC, INC.","65 W WATKINS MILL RD","","","N" "SBIR","Phase II","2006"," MARYLAND","IM ...... of Pathogenic Viruses on a Microfluidic Platform","Dr.
Entine, ...... RAYMOND ALLEN","Protection Against West Nile Virus by RNA
Interference" ...... PATRICK MARTIN","IPformatics: An Integrated Knowledgebase
of Patent ...
http://silk.nih.gov/public/cbz2zoz.@www.sbirsttr.fy2006.csv...

Coronary artery bypass graft - BioSpace offers Pharmaceutical ...
ev3 Inc. Receives FDA Clearance For SpideRX(TM) Embolic Protection Device For .... Term Coronary Health Benefits Of The m.doc(TM) Technology Platform And An
Additive ... GenVec Inc. (GNVC) Launches Phase IIB Trial In Patients With Severe
... Lawsuit To Revoke Angiotech Pharmaceuticals (ANPI) Patent 2/18/2005 More.
...
http://www.biospace.com/news_by_disease_results.aspx?TheRxId...

NIH SMALL BUSINESS INNOVATIVE RESEARCH AWARDS Fiscal Year ...
Diiorio, Mark S 5R43EB001745-02 $120080 Nanotechnology platform for ..... Raymond Allen 5R41AI058624-02 $361752 Protection Against West Nile Virus by RNA
...... 65 W WATKINS MILL RD MARYLAND, GAITHERSBURG (ZIP 20878-4021): GENVEC, INC
. ...... Knowledgebase of Patent Claims and Genomic Data MSN 4D4 VIRGINIA, ...
http://silk.nih.gov/public/cbz2zoz.@www.sbirsttr.fy2006.txt...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.